AR and prostate carcinoma: This reprogramming has far-reaching consequences, in which a distinct and unique gene set with acquired AR-responsive features provides prognostic potential for the survival of patients with prostate cancer, independent of classical prognostic parameters and clinical risk stratification system (D’Amico).